Navigation Links
Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
Date:2/29/2012

43Operating income9,849,4876,501,7475,776,635Interest income210,727200,20779,363Interest expense(353,497)(1,423,523)(772,927)Income before income taxes9,706,7175,278,4315,083,071Income tax expense(4,080,204)(2,851,420)(2,024,192)Net income5,626,5132,427,0113,058,879Net loss at subsidiary attributable to noncontrolling interests31,34329,66932,536Net income attributable to common shareholders$
5,657,856$
2,456,680$
3,091,415Earnings per share attributable to common shareholders- Basic$
.28$
.12$
.22- Diluted$
.28$
.12$
.17Weighted-average shares outstanding- Basic20,342,91320,333,93214,199,479- Diluted20,572,13221,058,57718,234,171CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIESCondensed Consolidated Statements of Cash Flows(Unaudited)Years ended December 31, 2011, 2010 and 2009201120102009Cash flows from operating activities:Net income$
5,626,513$
2,427,011$
3,058,879Adjustments to reconcile net income to net cash flows provided byoperating activities:Depreciation and amortization expense1,040,407978,398816,499Deferred tax expense (benefit)1,665,110(332,349)(525,467)Stock-based compensation - nonemployees149,71980,2221,056,401Stock-based compensation – employees629,586688,408606,395Excess tax benefit derived from exercise of stock options(2,355,345)(3,874,966)(3,968,894)Noncash interest expense137,487352,484128,800Net changes in assets and liabilities affecting operating activities:Accounts receivable(1,937,396)1,031,091(3,047,238)Inventory1,909,148(2,860,969)(3,060,097)Prepaid, other current assets and other assets(399,393)1,342,032(721,464)Accounts payable and other accrued liabilities2,296,535201,7256,572,098Other long-term obligations(40,224)313,575(510,942)Net cash provided by operating activities8,722,147346,662404,970Cash flows from investing activities:Additions to property and equipment(257,502)(577,159)(601,802)Additions to trademarks and patents(180,269)(191,483)(110,541)Net cash used in investing activities(437,77
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
5. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
6. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 25, 2015 Research ... announced the addition of the "2015 Strategies ... to their offering. This comprehensive five-country ... designed to help current suppliers and potential market ... the European coagulation testing market during the next ...
(Date:5/27/2015)... DUBLIN , May 25, 2015 ... addition of the "2015 Strategies in the ... offering. This comprehensive seven-country report contains ... help current suppliers and potential market entrants identify ... coagulation testing market during the next five years. ...
(Date:5/27/2015)... LAKE CITY , May 27, 2015  Vital ... a $10 million credit facility with Deerfield Management, a ... used to fund Vital Access, continued global expansion of ... further investment in the Company,s proprietary vascular access platform. ... Deerfield as a financial partner. Deerfield is a healthcare ...
Breaking Medicine Technology:European Coagulation Testing Market Strategies 2015 2Global Coagulation Testing Market Strategies 2015 2Global Coagulation Testing Market Strategies 2015 3Vital Access Receives $10 Million Financing Commitment from Deerfield 2Vital Access Receives $10 Million Financing Commitment from Deerfield 3
... 7, 2011 EntreMed, Inc. (Nasdaq: ENMD ... treatment of cancer, today announced that Selected Value Therapeutics ... an exclusive license to develop and commercialize EntreMed,s Phase ... of its territories.  EntreMed retains development and commercialization rights ...
... June 7, 2011 Topaz Pharmaceuticals Inc., a privately ... Food and Drug Administration (FDA) accepted for filing the ... topical cream as a treatment for head lice infestations ... represents the transition of the Company from the development ...
Cached Medicine Technology:Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China 2Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China 3Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China 4Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA 2Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA 3
(Date:5/27/2015)... Hampshire (PRWEB) May 27, 2015 In ... the April 2015 issue of the Journal of American ... sodas and abdominal obesity, Bedford Commons OB-GYN P.A ... instead of non-nutritive sweetener-flavored beverages. , To examine ... circumference, a comprehensive San Antonio Longitudinal Study of Aging ...
(Date:5/27/2015)... CURE® Magazine and the Bladder ... advance research, provide information and support, and raise awareness ... fifth most common type of cancer, which begins when ... out of control. , “CURE Magazine provides guidance ... the cancer experience through digital and print publications, live ...
(Date:5/27/2015)... Little Rock, AR (PRWEB) May 27, 2015 ... and Medix today announce a partnership to provide ... the Medix community. This collaboration seeks to strengthen ... skills measurement through CMSA’s CKP program. The mutually ... focused on identifying individual skills of talent in ...
(Date:5/27/2015)... May 27, 2015 The MedSpa at ... FDA-approved dermal filler treatments in Abilene, Texas: Xeomin®, Belotero ... the appearance of glabellar lines, better known as the ... Balance® is designed to treat smoker’s lines around the ... chin, while Radiesse® improves the appearance of smile lines ...
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 – Memorial Hospital, ... provider along the Gulf Coast to pioneer a ... partnership with MD Revolution, a digital care management ... that enables healthcare providers to easily meet Medicare’s ... user-friendly program is designed to improve patient engagement, ...
Breaking Medicine News(10 mins):Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3
... ... of the non-biodegradable trash worldwide. With its tobacco alternative products, e-cigs, Smart Smoke has ... , ... 25, 2010 -- With more than 5,000 new customers in less than a year, Spokane ...
... Baden ... Vision-Robbing Condition called Retinitis Pigmentosa , ... Brandywine, MD (PRWEB) -- The students of Baden Elementary School will participate ... Foundation Fighting Blindness . The event was organized by Baden sixth grader, Bjorn Brooks, who ...
... ... Caseldine, D.D.S., was awarded Mastership accreditation at the 2010 International Congress of Oral Implantologists ... Implant Prosthodontics. , ... Phoenix, AZ (PRWEB) May 25, 2010 -- The International Congress of Oral Implantologists (ICOI) ...
... new rule preventing medical support staff from completing orders ... negative resulted in a marked decrease in low-yield exams ... June issue of Radiology . Many medical ... use of web-based radiology order entry systems. Some systems ...
... of kidney transplant rejection and acceptance Three ... recipients likely to maintain excellent and stable allograft function ... risk of losing their transplants. Peter Heeger and Bernd ... describe in an accompanying commentary, the importance of these ...
... ... by taking the top medal in SharpBrains first annual Brain Fitness Innovation Awards . ... San Francisco, ... by taking the top medal in SharpBrains first annual Brain Fitness Innovation Awards . ...
Cached Medicine News:Health News:10 Million Cigarette Butts Prevented from Touching the Ground in Spokane County, Washington, Thanks to Smart Smoke Electronic Cigarette 2Health News:Baden Elementary School holds VisionWalk to Fight Blindness 2Health News:Baden Elementary School holds VisionWalk to Fight Blindness 3Health News:Arizona Dentist Bestowed Prestigious Mastership Accreditation From ICOI 2Health News:Simple change results in fewer unnecessary imaging exams for patients 2Health News:JCI table of contents: May 24, 2010 2Health News:JCI table of contents: May 24, 2010 3Health News:JCI table of contents: May 24, 2010 4Health News:JCI table of contents: May 24, 2010 5Health News:JCI table of contents: May 24, 2010 6Health News:JCI table of contents: May 24, 2010 7Health News:JCI table of contents: May 24, 2010 8Health News:JCI table of contents: May 24, 2010 9Health News:USA Hockey Takes Gold at Brain Fitness Innovation Awards; Allstate & Nationwide Mutual Insurance Runners-up 2Health News:USA Hockey Takes Gold at Brain Fitness Innovation Awards; Allstate & Nationwide Mutual Insurance Runners-up 3Health News:USA Hockey Takes Gold at Brain Fitness Innovation Awards; Allstate & Nationwide Mutual Insurance Runners-up 4
... chemical fumes, allowing safe indoor ... filters remove most organic contaminants. ... flow speed = 100 fpm ... air speed monitor, quick-release filter/blower ...
... This modular benchtop fume ... fumes, allowing safe indoor release ... remove most organic contaminants. Configurations ... horizontal flow; options include final ...
... These corrosion proof polypropylene exhaust hoods are ... of tanks and draw a stream of ... away from the operator. Other sizes and ... lateral, and double-slot are available on special ...
These handy dispensers save space and organize gloves in labs and next to hand washers. Static-dissipative PVC eliminates static charges and the particles they attract . Many other sizes and custom c...
Medicine Products: